![]() “ was consistent with our major competitors in the US,” he said. ![]() The US pathology business, which accounts for 21 per cent of revenue, had volume growth of 2.2 per cent, but revenue growth was flat. ![]() UBS analyst Andrew Goodsall said the result benefited from a “solid portfolio effect”. On a geographic split, Sonic now has more than half (51 per cent) of its revenue coming from offshore. Australian imaging and medical centres both had revenue growth of 5 per cent to $415 million and $349 million respectively. Australian pathology, which accounts for 29 per cent of revenue, had sales growth of 6 per cent.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |